Literature DB >> 18400835

Functional epitope of muscarinic type 3 receptor which interacts with autoantibodies from Sjogren's syndrome patients.

N-Y Koo1, J Li, S-M Hwang, S-Y Choi, S J Lee, S-B Oh, J-S Kim, E B Lee, Y W Song, K Park.   

Abstract

OBJECTIVES: Recently, autoantibodies directed against muscarinic type 3 receptor (M3R) have been reported in patients with primary SS. However, the precise epitope(s) of the M3R that interacts with SS autoantibodies remains unclear. The aim of this study was to identify the functional epitope of M3R which interacts with SS immunoglobulin G (IgG).
METHODS: Purified IgGs were obtained from the sera of seven SS patients (six primary and one secondary SS) and two normal persons. We examined whether SS IgG inhibits M3R function and identified the epitope using six synthetic peptides covering all the extracellular domains of M3R by microspectrofluorimetry and surface plasmon resonance-based optical biosensor system (BIAcore system).
RESULTS: A volume of 0.5 mg/ml SS IgG inhibited carbachol (CCh)-induced [Ca(2+)](i) transient (CICT) in human submandibular gland (HSG) cells. However, co-incubation of SS IgG with the 6th peptide (514-527 amino acid region) corresponding to the third extracellular loop of M3R, recovered CICT. The result was further confirmed by BIAcore analysis. We found that the 6th peptide interacts with IgGs from three primary SS patients in a concentration-dependent manner. The synthetic peptide which consists of amino acids 228-237 corresponding to the COOH-terminus of the second extracellular loop of M3R also bound to SS IgG. However, normal IgGs did not interact with the 6th peptide.
CONCLUSIONS: The results suggest that the third extracellular loop of M3R represents a functional epitope bound by SS IgG, and thereby partly inhibits M3R function.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18400835     DOI: 10.1093/rheumatology/ken064

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  15 in total

Review 1.  Pathogenesis of Sjögren's syndrome.

Authors:  Nikolay P Nikolov; Gabor G Illei
Journal:  Curr Opin Rheumatol       Date:  2009-09       Impact factor: 5.006

Review 2.  Sjögren syndrome: advances in the pathogenesis from animal models.

Authors:  J A Chiorini; D Cihakova; C E Ouellette; P Caturegli
Journal:  J Autoimmun       Date:  2009-10-02       Impact factor: 7.094

Review 3.  Autoantibodies as Endogenous Modulators of GPCR Signaling.

Authors:  Meredith A Skiba; Andrew C Kruse
Journal:  Trends Pharmacol Sci       Date:  2020-12-24       Impact factor: 14.819

4.  New epitopes and function of anti-M3 muscarinic acetylcholine receptor antibodies in patients with Sjögren's syndrome.

Authors:  H Tsuboi; I Matsumoto; E Wakamatsu; Y Nakamura; M Iizuka; T Hayashi; D Goto; S Ito; T Sumida
Journal:  Clin Exp Immunol       Date:  2010-08-20       Impact factor: 4.330

5.  Muscarinic type 3 receptor induces cytoprotective signaling in salivary gland cells through epidermal growth factor receptor transactivation.

Authors:  Mikihito Kajiya; Isao Ichimonji; Christine Min; Tongbo Zhu; Jun-O Jin; Qing Yu; Soulafa A Almazrooa; Seunghee Cha; Toshihisa Kawai
Journal:  Mol Pharmacol       Date:  2012-04-17       Impact factor: 4.436

Review 6.  Agonistic autoantibodies directed against G-protein-coupled receptors and their relationship to cardiovascular diseases.

Authors:  Gerd Wallukat; Ingolf Schimke
Journal:  Semin Immunopathol       Date:  2014-04-29       Impact factor: 9.623

7.  Muscarinic type 3 receptor autoantibodies are associated with anti-SSA/Ro autoantibodies in Sjögren's syndrome.

Authors:  Jian Zuo; Adrienne E G Williams; Yun-Jong Park; Kevin Choi; Annie L Chan; Westley H Reeves; Michael R Bubb; Yun Jong Lee; Kyungpyo Park; Carol M Stewart; Seunghee Cha
Journal:  J Immunol Methods       Date:  2016-07-25       Impact factor: 2.303

8.  Effects of scleroderma antibodies and pooled human immunoglobulin on anal sphincter and colonic smooth muscle function.

Authors:  Jagmohan Singh; Sidney Cohen; Vaibhav Mehendiratta; Fabian Mendoza; Sergio A Jimenez; Anthony J Dimarino; Satish Rattan
Journal:  Gastroenterology       Date:  2012-08-01       Impact factor: 22.682

9.  A novel luminescence-based method for the detection of functionally active antibodies to muscarinic acetylcholine receptors of the M3 type (mAchR3) in patients' sera.

Authors:  B Preuss; S Tunaru; J Henes; S Offermanns; R Klein
Journal:  Clin Exp Immunol       Date:  2014-07       Impact factor: 4.330

10.  Effects of muscarinic acetylcholine 3 receptor(208-227) peptide immunization on autoimmune response in nonobese diabetic mice.

Authors:  Lin Yang; Jinzhe Ju; Wei Zhang; Fengfeng Lv; Chunyan Pang; Guoan Yang; Yongfu Wang
Journal:  Clin Dev Immunol       Date:  2013-12-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.